{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:28:01Z","timestamp":1779064081405,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016304","name":"Medtronic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jval.2020.12.021","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T22:06:49Z","timestamp":1617314809000},"page":"930-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England"],"prefix":"10.1016","volume":"24","author":[{"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Kennergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaldoun G.","family":"Tarakji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fozia Z.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet M.","family":"McComb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Goette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Shore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong Lien","family":"Carion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce L.","family":"Wilkoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.jval.2020.12.021_bib1","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/eurheartj\/eht150","volume":"34","author":"Brignole","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jac\/dku383","volume":"70","author":"Sandoe","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jval.2020.12.021_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/europace\/euz246","volume":"22","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.jval.2020.12.021_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008280","article-title":"Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT Trial","volume":"13","author":"Wilkoff","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jval.2020.12.021_bib5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/europace\/eux387","article-title":"Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study","volume":"20","author":"Clementy","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib6","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/europace\/euu126","article-title":"A\u00a0simple infection-control protocol to reduce serious cardiac device infections","volume":"16","author":"Ahsan","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/cer-2017-0080","article-title":"Incidence and costs of cardiac device infections: retrospective analysis using German health claims data","volume":"7","author":"Ludwig","year":"2018","journal-title":"J\u00a0Com Eff Res"},{"key":"10.1016\/j.jval.2020.12.021_bib8","first-page":"464","article-title":"Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis","volume":"22","author":"Burnhope","year":"2019","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jval.2020.12.021_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/europace\/euy291","article-title":"Real-world costs of transvenous lead extraction: the challenge for reimbursement","volume":"21","author":"Brough","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213682","article-title":"Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study","volume":"14","author":"Ahmed","year":"2019","journal-title":"PLoS One"},{"issue":"suppl. 1","key":"10.1016\/j.jval.2020.12.021_bib11","doi-asserted-by":"crossref","first-page":"i180","DOI":"10.1093\/europace\/euy015.525","article-title":"Economic impact associated with complications of cardiac implantable electronic devices in Spain (Abstract)","volume":"20","author":"Egea","year":"2018","journal-title":"EP Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis","volume":"17","author":"Polyzos","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","article-title":"Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark","volume":"35","author":"Kirkfeldt","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib14","first-page":"1","article-title":"Economic impact of cardiac implantable electronic device infections: Cost analysis at one year in a large United States health insurer","author":"Eby","year":"2020","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jval.2020.12.021_bib15","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008","volume":"58","author":"Greenspon","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jval.2020.12.021_bib16","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jacc.2019.09.060","article-title":"Risk factors for infections involving cardiac implanted electronic devices","volume":"74","author":"Birnie","year":"2019","journal-title":"JACC"},{"key":"10.1016\/j.jval.2020.12.021_bib17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1901111","article-title":"Antibacterial envelope to prevent cardiac implantable device infection","volume":"380","author":"Tarakji","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jval.2020.12.021_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.02.011","article-title":"The World-Wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) Trial: long-term follow-up","author":"Mittal","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jval.2020.12.021_bib19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/eurheartj\/eht031","article-title":"Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association","volume":"34","author":"Boriani","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib20","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/europace\/eur088","article-title":"Economic evaluation in cardiology","volume":"13","author":"Maniadakis","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jval.2020.12.021_bib21","first-page":"294","article-title":"Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection","volume":"21","author":"Kay","year":"2018","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jval.2020.12.021_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ahj.2016.06.010","article-title":"Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT)","volume":"180","author":"Tarakji","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib23","article-title":"Geographical variations in the incidence of CIED infection and infection prevention strategies: update from the Global WRAP-IT Study","author":"Kennergren","year":"2020","journal-title":"EHRA presentation"},{"key":"10.1016\/j.jval.2020.12.021_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40273-018-0672-z","article-title":"Discounting in economic evaluations","volume":"36","author":"Attema","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.12.021_bib25","series-title":"Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure [TA314]","year":"2014"},{"key":"10.1016\/j.jval.2020.12.021_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03320660","article-title":"Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia","volume":"11","author":"Fattore","year":"2009","journal-title":"PharmacoEconomics Italian Research Articles"},{"key":"10.1016\/j.jval.2020.12.021_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2018.1447828","article-title":"On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review","volume":"11","author":"Cameron","year":"2018","journal-title":"Glob Health Action"},{"key":"10.1016\/j.jval.2020.12.021_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hec.3946","article-title":"The marginal benefits of healthcare spending in The Netherlands: estimating cost-effectiveness thresholds using a translog production function","volume":"28","author":"Stadhouders","year":"2019","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2020.12.021_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hec.3831","article-title":"A\u00a0cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending","volume":"28","author":"van Baal","year":"2019","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2020.12.021_bib30","series-title":"Guide to the methods of technology appraisal","year":"2013"},{"key":"10.1016\/j.jval.2020.12.021_bib31","series-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"10.1016\/j.jval.2020.12.021_bib32","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/eurheartj\/ehz316","article-title":"Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018)","volume":"40","author":"Olsen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib33","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2020.12.021_bib34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jce.12684","article-title":"Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation","volume":"26","author":"Shariff","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jval.2020.12.021_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/eurheartj\/ehp421","article-title":"Prevalence and risk factors related to infections of cardiac resynchronization therapy devices","volume":"31","author":"Romeyer-Bouchard","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jval.2020.12.021_bib36","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.hrthm.2011.10.034","article-title":"Cardiac device infections are associated with a significant mortality risk","volume":"9","author":"de Bie","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jval.2020.12.021_bib37","doi-asserted-by":"crossref","first-page":"e008503","DOI":"10.1161\/CIRCEP.120.008503","article-title":"Cost-effectiveness of an antibacterial envelope for CIED infection prevention in the US healthcare system from the WRAP-IT Trial","volume":"13","author":"Wilkoff","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:23:12Z","timestamp":1761096192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1098301521001108"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.12.021","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}